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S U M M A R Y
Objectives: Fingerprinting of Mycobacterium tuberculosis complex strains based on the IS6110 insertion
sequence would considerably gain in terms of discriminatory power and versatility if both 50 and 30
polymorphisms were simultaneously targeted, and if it beneﬁted from automated capillary
electrophoresis. In response to these requirements, we developed IS6110-5030FP (IS6110 50 and 30
ﬂuorescent polymorphisms).
Methods: IS6110-5030FP involves the construction of an M. tuberculosis genomic library in a plasmid
vector using HincII endonuclease, which cuts within the IS6110 sequence. After ampliﬁcation in
Escherichia coli, the library is subjected to selective and simultaneous PCR ampliﬁcation of IS6110 50 and
30 polymorphic fragments, using differentially labeled ﬂuorescent primers. The resulting amplicons are
then fractionated on a capillary sequencer and the signal peaks analyzed as digital data.
Results: IS6110-5030FP consistently detected and resolved both 50 and 30 IS6110 polymorphic fragments
(35% and 65%, respectively) with a high level of reproducibility. The method differentiated all M.
tuberculosis strains, as did IS6110 restriction fragment length polymorphism (RFLP), the gold standard of
IS6110-based typing. Strikingly, the potential of IS6110-5030FP to resolve more polymorphic fragments
than IS6110 RFLP was demonstrated.
Conclusions: IS6110-5030FP demonstrated sufﬁcient potential to be a promising automated alternative to
IS6110 RFLP, amenable to high throughput analysis and inter-laboratory comparison.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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The early detection of tuberculosis (TB) outbreaks, particularly
those involving multidrug-resistant (MDR) or extensively drug-
resistant (XDR) Mycobacterium tuberculosis strains, is critical to
prevent further expansion to the wider community.1,2 The
application of molecular tools has signiﬁcantly improved our
ability to detect recent or ongoing transmission events and to
monitor their eventual spread, even in the absence of epidemio-
logical data.3–5
IS6110 restriction fragment length polymorphism (IS6110 RFLP)
and mycobacterial interspersed repetitive units–variable number
tandem repeats (MIRU-VNTR) are the most discriminatory* Corresponding author. Tel.: +216 71 845368; fax: +216 71 791833.
E-mail address: helmi.merdassi@pasteur.rns.tn (H. Mardassi).
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).techniques allowing for the detection of recent or ongoing TB
transmission events.6–9 IS6110 RFLP has long been considered the
gold standard for discriminating M. tuberculosis complex (MTBC)
strains.6,10 It has proved instrumental in detecting outbreaks,
reactivation, and laboratory contaminations. Unfortunately, as a
hybridization-based method, IS6110 RFLP requires large amounts
of DNA and is labor-intensive and time-consuming. In addition,
IS6110 RFLP cannot efﬁciently discriminate strains with low IS6110
copy numbers (less than ﬁve copies).11,12 Another major drawback
of IS6110 RFLP is the fact that the resulting ﬁngerprinting proﬁles
are not suitable for data banking or inter-laboratory comparisons.
In recent years, MIRU-VNTR has gained much interest as an
alternative to IS6110 RFLP since it relies on PCR ampliﬁcation, and
thus requires much less starting DNA. Importantly, the 24-locus
MIRU-VNTR format has demonstrated a discriminatory power
equal to that of IS6110 RFLP and has proved more efﬁcient in
discriminating M. tuberculosis strains with few copies of the IS6110ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
S. Thabet et al. / International Journal of Infectious Diseases 29 (2014) 211–218212element.13,15–17 Unlike IS6110 RFLP, the use of MIRU-VNTR is
amenable to automation and provides portable typing data. MIRU-
VNTR, particularly in its 24-locus format, is now recognized as the
international new gold standard for MTBC strain typing and cluster
analyses.15,18
However, we feel that IS6110-based typing could be improved
further in terms of both discrimination power and ﬂexibility.
Indeed, and as far as could be ascertained, most, if not all, of the
ﬁngerprinting methods based on the IS6110 element, target either
the 50 or 30 polymorphism but not both. Therefore, one could
reasonably argue that the discriminatory power of IS6110-based
typing would be improved considerably if both 50 and 30
polymorphisms were targeted simultaneously. We also believe
that IS6110-based typing could considerably beneﬁt from the high
resolution of capillary electrophoresis and the portability of its
output format, thus tackling the major drawbacks of IS6110 RFLP.
Towards this end, we developed a new IS6110-based typing
approach, IS6110-5030FP (IS6110 50 and 30 ﬂuorescent polymor-
phisms), which aside from being PCR-based, addresses all of the
above requirements. IS6110-5030FP is a modiﬁcation of a previously
described approach that we termed GL-PCR (genomic library-
based ampliﬁcation).19 The latter cloning/PCR-based method has
two distinctive features: (1) IS6110-containing fragments are ﬁrst
pre-ampliﬁed in Escherichia coli as part of a genomic plasmid
library, and (2) both sides of the IS6110 element are targeted by
PCR ampliﬁcation using 50 and 30 outward primers in combination
with a primer whose binding site is located upstream or
downstream of the plasmid cloning site (T7 or T3 primer). In a
previous study, we showed the discriminatory power of GL-PCR to
be equal to that of IS6110 RFLP.19 IS6110-5030FP, by differentially
labeling and automatically fractionating IS6110 50 and
30polymorphic fragments, adds a new level to the resolution
power and versatility of IS6110-based ﬁngerprinting. IS6110-5030FP
could thus be used in combination with MIRU-VNTR for a thorough
description of microevolution events and for more detailed
analyses of TB transmission, particularly when it involves certain
M. tuberculosis lineages that are poorly discriminated by MIRU-
VNTR.
2. Materials and methods
2.1. Bacterial strains
The feasibility and reproducibility of IS6110-5030FP was
evaluated using an M. tuberculosis clinical strain of the Haarlem
3 genotype, involved in an MDR-TB outbreak in Tunisia. The IS6110
RFLP proﬁle of this outbreak strain shows 11 bands.20 To test the
performance of IS6110-5030FP, we used 12 genetically unrelated M.
tuberculosis clinical isolates of the Latin American and Mediterra-
nean (LAM) genotype. These isolates, chosen from a previously
characterized and published collection,21 were subjected to IS6110
RFLP typing according to the standardized protocol.6,21 M.
tuberculosis strains were cultured on Lo¨wenstein–Jensen medium.
For cloning purposes we used E. coli strain TOP10 (Invitrogen),
which was grown on lysogeny broth (LB) medium supplemented
with ampicillin at 100 mg/ml.
2.2. IS6110-5030FP protocol
The IS6110-5030FP protocol is depicted in Figure 1. Brieﬂy,
mycobacterial genomic DNA was extracted from one loopful of
bacteria (two to three colonies) and cultured on Lo¨wenstein–
Jensen medium, according to standard recommendations.6 DNA
was fully digested with HincII, a restriction enzyme that produces
blunt-ended products, which cuts two times in the middle of the
IS6110 sequence and 7445 times in the chromosomal DNA of theM. tuberculosis reference strain, H37Rv. Restricted DNA was ligated
into EcoRV-linearized and dephosphorylated plasmid pBS SK+
(Stratagene). Typically, 150 ng of HincII-restricted mycobacterial
DNA was combined with 50 ng of linearized plasmid vector in a
ligation reaction.
The entire ligation product was then transformed into
competent TOP10 E. coli and incubated overnight at 37 8C in the
presence of ampicillin. The genomic plasmid library DNA was
recovered by alkaline minipreparation from the whole transfor-
mation product using Qiagen columns. All DNA manipulations
including plasmid preparation, endonuclease restriction, ligation,
and plasmid transformation, were performed according to
standard protocols.22 Restriction endonucleases and other
enzymes were used as recommended by the supplier (Amersham
Biosciences).
To simultaneously target the 30 and 50 polymorphisms of IS6110,
we performed a single PCR reaction involving the T7 primer and
the two outward IS6110-speciﬁc primers IS1 (GGCTGAGGTCTCA-
GATCAG) and IS2 (ACCCCATCCTTTCCAAGAAC),38 ﬂuorescently
labeled with FAM and JOE dyes, respectively. Typically, 20 ng of
a plasmid minipreparation of the genomic library were used as
template in the PCR ampliﬁcation. The latter consisted of 1
EUROBIOTAQ II buffer (EUROBIO, France; 6.7 mM Tris–HCl (pH
8.8), 16 mM (NH4)2SO4, 0.01% Tween 20, 3 mM MgCl2), a 1 mM
concentration of each primer (Amersham Biosciences), a 50 mM
concentration of each deoxynucleotide triphosphate, and 1.5 U of
EUROBIOTAQ II polymerase. The reaction was thermal-cycled once
at 94 8C for 5 min, 35 times at 94 8C for 1 min, 55 8C for 1 min, 72 8C
for 1 min, and then once at 72 8C for 10 min. The ampliﬁcation
reaction was performed in a Perkin Elmer GeneAmp PCR system
9700 (Applied Biosystems Inc., CA, USA). The PCR products were
analyzed by electrophoresis on 1% agarose gels, stained with
ethidium bromide and visualized on a UV transilluminator (BioDoc
Analyze, Biometra).
As negative control we performed a PCR reaction using the
product of a pBS SK+ plasmid auto-ligation reaction as template
DNA.
2.3. Automated fragment size fractionation of IS6110-5030FP
generated products
IS6110-5030FP products were diluted 1/20, and 1 ml of the
dilution was mixed with 0.5 ml of GeneScan 1200 LIZ and 9 ml of
Hi-Di Formamide. The mix was denatured for 2 min at 95 8C.
Automated fragment analysis was performed using LIZ 1200 as a
DNA size marker on an ABI PRISM 3100 capillary DNA sequencer
(Applied Biosystems Inc., CA, USA). The electrophoresis was done
using POP-7 Polymer and a 50-cm length capillary. Electrophoresis
parameters were set according to the 3130_50cm_POP-
7_GS1200LIZ run module (Applied Biosystems Inc., CA, USA).
2.4. Data analysis
Chromatographs showing FAM- and JOE-ﬂuorescing fragments
were imported into GeneMapper software v. 4 (Applied Biosys-
tems) and analyzed using ampliﬁed fragment length polymor-
phism (AFLP) default and the advanced mode with selection of a
starting point of electrophoresis at 3250 data point. The threshold
for assigning a peak was set to 200 relative ﬂuorescence units
(RFU), based on preliminary experiments using a negative control
(IS6110-5030FP auto-ligation product), whose ﬂuorescence peaks
were reduced to less than 50 RFU at the 1/20 dilution. The size of
fragments was determined using GeneScan 1200 LIZ v. 2 (Applied
Biosystems) with a sizing quality >0.95, and veriﬁed using the plot
determined by the software. GeneMapper also recorded the
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Figure 1. Overview of the IS6110-5030FP method. Additional details are provided in the Materials and methods. Note that because cloning is non directional (blunt-end
ligation), effective PCR ampliﬁcation of any given IS6110 polymorphic fragment takes place only when it is inserted in the right orientation, which basically occurs as
frequently as the opposite orientation. Therefore, the use of a single primer in the plasmid (T7 primer here) ensures efﬁcient ampliﬁcation of all polymorphic fragments.
S. Thabet et al. / International Journal of Infectious Diseases 29 (2014) 211–218 213into BioNumerics v. 6.1, visualized as virtual electrophoresis gels,
and analyzed. Two IS6110-5030FP proﬁles were considered to be
different if they had at least one peak difference. Two peaks with a
size difference of less than 0.25 bp (2 the highest standard
deviation value obtained in the reproducibility analysis) were
considered identical.
2.5. Reproducibility study
To assess the reproducibility of IS6110-5030FP, three indepen-
dent ampliﬁcations were performed using DNA extracted from
three different genomic plasmid libraries of the 11-band M.
tuberculosis clinical isolate. PCR products were then used in three
separate capillary runs to test for the reproducibility of the signals
in terms of both size and intensity.2.6. Statistical analyses




To avoid background signals, dilutions of the IS6110-5030FP
auto-ligation product (negative control) were run ﬁrst on the
capillary sequencer and the data analyzed. As shown in Figure 2, a
dilution of 1/20 was sufﬁcient to reduce background signals to
levels <50 RFU. The same experiment was repeated twice and gave
Figure 2. Elimination of IS6110-5030FP background signal. IS6110-5030FP was performed using the auto-ligation product of pBS SK+ plasmid vector. The products were
fractionated without being diluted (panels A and D), diluted 1/10 (B and E), or 1/20 (C and F) on an ABI PRISM 3100 capillary DNA sequencer (Applied Biosystems Inc., CA, USA).
Panels A to C and D to F show FAM- and JOE-ﬂuorescing peaks, respectively. x-axis = fragment size in base pairs (bp); y-axis = ﬂuorescence intensity in relative ﬂuorescence
units (RFU). The red dashed vertical and horizontal lines correspond to the size and ﬂuorescence intensity thresholds (122–126 bp and 200 RFU), respectively.
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20 was adopted and the threshold for positivity was set to 200 RFU.
With regards to the size threshold for ampliﬁed fragments,
based on the cloning procedure and the location of the PCR
primers, the expected smallest IS6110-5030FP product (which
would result from the occurrence of a HincII site immediately at
either end of the IS6110 element) should display a size of 126 bp
with FAM and 122 bp with JOE (the products of the primer pairs T7/
IS1 and T7/IS2, respectively). Consequently, FAM and JOE peaks
with respective sizes less than 126 bp and 122 bp were not
considered.
3.2. Feasibility and reproducibility of IS6110-5030FP
Taking into consideration the above parameters, we assessed
IS6110-5030FP in terms of efﬁcient band detection and, particularly,
its ability to detect both 50 and 30 polymorphisms. For this purpose,
we used a well characterized M. tuberculosis strain whose IS6110
RFLP proﬁle shows 11 bands. The IS6110-5030FP proﬁle of this 11-
band strain revealed a total of 16 ﬂuorescence peaks with an equal
number of FAM and JOE signals (Figure 3A), thus demonstrating
the efﬁcient targeting of both IS6110 50 and 30 polymorphisms. Thesizes of ﬂuorescent peaks varied from 126.97 bp to 567.91 bp. The
chromatograph showed three cases where FAM- and JOE-
ﬂuorescing peaks displayed very close molecular sizes
(166.12 bp/168.18 bp; 294.9 bp/295.45 bp; 447.82 bp/451.43 bp).
Of note, when the IS6110-5030FP products were fractionated on a 1%
agarose gel, only nine bands could be observed (Figure 3B).
To evaluate the reproducibility of IS6110-5030FP, we performed
three separate IS6110-5030FP reactions using the genomic DNA of
three independent cultures of the 11-band M. tuberculosis strain.
The resulting products were subjected to three independent
capillary electrophoresis runs. For comparative purposes, the three
IS6110-5030FP products were also run on an agarose gel. Figure 3B
shows the agarose gel analysis of the three independent IS6110-
5030FP products, which proved identical in size and intensity. After
capillary electrophoresis, the three chromatograms perfectly
superimposed with regard to fragment size. The 16 peaks yielded
nearly identical fragment sizes with very low standard deviation
values, varying from 0.020 to 0.086 and from 0.010 to 0.125 for
FAM- and JOE-ﬂuorescent peaks, respectively, thus showing a high
level of reproducibility (Figure 3). However, the signal intensity
was highly reproducible with FAM labeling, but signiﬁcant
variation was observed with JOE, yet all peaks gave values above
Figure 3. Feasibility and reproducibility of IS6110-5030FP. The ability of IS6110-5030FP to simultaneously target and resolve both the 50 and 30 polymorphism of IS6110 was
assessed using an IS6110 RFLP 11-band M. tuberculosis strain, whose chromatogram is depicted in panel A. This 11-band strain also served in the reproducibility study. Three
independent IS6110-5030FP reactions were performed and their corresponding agarose gel proﬁles are shown in panel B. Panel C shows the superimposition of the three
corresponding chromatograms in the molecular size window of 165–196 bp. Note that both FAM- and JOE-ﬂuorescing peaks perfectly superimposed with regard to fragment
size. x-axis = fragment size in base pairs (bp); y-axis = ﬂuorescence intensity in relative ﬂuorescence units (RFU). The red dashed vertical and horizontal lines correspond to the
size and ﬂuorescence intensity thresholds (122–126 bp and 200 RFU), respectively. Numbers on top of peaks in panels A and C represent the corresponding precise molecular
size. M: 100-bp ladder.
Figure 4. Performance of IS6110-5030FP as compared to IS6110 RFLP using a panel of
M. tuberculosis clinical isolates. The IS6110 RFLP proﬁle of 12 epidemiologically
distinct M. tuberculosis isolates of the Latin American and Mediterranean (LAM)
genotype is shown. For each strain, the number of IS6110 RFLP bands was compared
to that of IS6110-5030FP seen under UV light or detected after capillary
electrophoresis. *The corresponding chromatogram is depicted in Figure 5.
S. Thabet et al. / International Journal of Infectious Diseases 29 (2014) 211–218 215the threshold of 200 RFU. Therefore, there was no variation in the
number of detected peaks throughout the three independent
experiments.
3.3. Performance of IS6110-5030FP with a panel of 12 phylogenetically
distinct M. tuberculosis clinical isolates
To further evaluate the performance of IS6110-5030FP in
resolving a much greater number of polymorphic bands than
does IS6110 RFLP, we analyzed 12 phylogenetically distinct M.
tuberculosis clinical isolates with both methods. As shown in
Figure 4, the overall number of polymorphic bands detected by
IS6110 RFLP exceeded that of IS6110-5030FP by 21.29% (131 vs.
108), despite the fact that the former method targets only the 30
polymorphism. Nonetheless, IS6110-5030FP was able to detect
more polymorphic bands than IS6110 RFLP for three clinical strains
(0889/02, 1393/03, 2077/03). Hence, and taking into account the
result with the 11-band strain, IS6110-5030FP demonstrated its
potential to detect more polymorphic bands than IS6110 RFLP.
Importantly, IS6110-5030FP detected 19 additional polymorphic
fragments when amplicons were analyzed by capillary electro-
phoresis compared to agarose gel fractionation (108 vs. 89).
Finally, IS6110-5030FP appears to perform better with FAM than
with JOE labeling (71 vs. 37 peaks). A comparison of the
chromatograms of four different clinical strains is depicted in
Figure 5.
Figure 5. Representative chromatograms of four M. tuberculosis clinical strains (2066/02, 0889/02, 0876/02, 0794/03). x-axis = fragment size in base pairs (bp); y-axis =
ﬂuorescence intensity in relative ﬂuorescence units (RFU). The red dashed vertical and horizontal lines correspond to the size and ﬂuorescence intensity thresholds (122–
126 bp and 200 RFU), respectively.
S. Thabet et al. / International Journal of Infectious Diseases 29 (2014) 211–2182164. Discussion
Typing of MTBC strains based on the IS6110 insertion sequence
is still of great utility to further resolve MIRU-VNTR clusters,
particularly when it addresses high copy-number IS6110 MTBC
isolates.23–28 Nonetheless, as a cumbersome method that is not
amenable to high-throughput processing and data exchange,
IS6110 RFLP is likely to be abandoned. We have designed a new
IS6110-based typing approach, termed IS6110-5030FP, which not
only addresses the limitations of IS6110 RFLP in terms of rapidity
and versatility, but was conceived for increased resolution and
discriminatory power. The primary objective of the present study
was to assess the technical feasibility of IS6110-5030FP.
Unlike IS6110 RFLP, IS6110-5030FP relies on PCR ampliﬁcation of
IS6110 polymorphic fragments and is readily performed with a
limited quantity of DNA. In our hands, genomic DNA extracted
from two to three bacterial colonies proved sufﬁcient to provide
interpretable typing results (data not shown). Moreover, IS6110-
5030FP polymorphic fragments beneﬁt from a pre-ampliﬁcation
step in E. coli, as part of the genomic plasmid library. Several PCR-
based modalities targeting IS6110 have been developed thus far,
but none has involved a pre-ampliﬁcation step.29–35 This distinc-
tive feature is likely to endow IS6110-5030FP with increased
performance in cases where the starting amount of DNA is very
low.
Although IS6110-5030FP involves plasmid cloning and E. coli
transformation steps, the method could easily be implemented in
laboratories that are not acquainted with molecular cloning
techniques. Indeed, the cloning step can readily be ensured by
making use of the ready-to-use blunt-end cloning kits. In doing so,
the operator will have only to restrict DNA and then follow themanufacturer’s instructions to clone and to transform E. coli. PCR
ampliﬁcation is then performed on a one-night E. coli culture
lysate. In fact, the E. coli transformation step can be omitted, since
in our hands IS6110-5030FP works very efﬁciently using the ligation
product as a template for PCR ampliﬁcation. With this modiﬁca-
tion, one can obtain IS6110-5030FP products within 4 h (1 h
restriction enzyme digestion + 1 h ligation + 2 h PCR) and can
then proceed with fragment size analysis on a capillary sequencer
as for the other techniques.
It has been shown previously that the discriminatory power of
IS6110 RFLP can be increased when RFLP membranes are reprobed
with an IS6110 left-hand probe (IS6110-50).36 In IS6110-5030FP, the
simultaneous detection of IS6110 50 and 30 polymorphisms was
made possible using differentially labeled IS6110 outward primers,
while optimal resolution of both polymorphisms was achieved by
capillary fractionation on an automated DNA sequencer. To our
knowledge, IS6110-5030FP is the ﬁrst approach to combine these
features and will certainly be useful in certain areas, like India,
where a large proportion of circulating M. tuberculosis strains have
a limited number of IS6110 elements.37
The major advantage of IS6110 over MIRU-VNTR is that it relies
on a single PCR reaction. However, as mentioned above, since these
methods target different genetic markers, they should be
combined for optimal strain differentiation. With regard to the
existing IS6110-based approaches that combine PCR ampliﬁcation
and capillary fractionation, like ﬂuorescent AFLP (fAFLP),34 IS6110-
5030FP offers the advantage of targeting both IS6110 ends, and is
therefore expected to have increased discrimination power.
Since IS6110-5030FP targets and resolves the polymorphism on
both sides of IS6110, the number of resolved ﬂuorescent peaks for
any given strain would be at least double the number of IS6110
S. Thabet et al. / International Journal of Infectious Diseases 29 (2014) 211–218 217RFLP apparent bands. The potential of IS6110-5030FP to detect more
polymorphic fragments than IS6110 RFLP was demonstrated with a
few strains, but in no case was the number of resolved peaks twice
the number of IS6110 RFLP bands. In our opinion, this is most likely
due to the fact that digestion with a single restriction enzyme,
HincII in this case, still leaves large DNA fragments that are
refractory to cloning and PCR ampliﬁcation. Therefore, using a pair
of restriction enzymes, or a single enzyme that cuts much more
frequently than does HincII, would greatly increase the sensitivity
of IS6110-5030FP. Our initial attempts using our reference 11-band
outbreak strain yielded promising results when HincII was used in
combination with StuI, as the IS6110-5030FP proﬁle revealed two
additional polymorphic bands under UV light (Supplementary
Material, Figure S1).
On the other hand, the number of IS6110-5030FP ﬂuorescent peaks
could be signiﬁcantly inﬂuenced by the stability and the extinction
coefﬁcient of the ﬂuorescent dyes. Our results suggest that the FAM
dye performed better than JOE. Indeed, FAM-ﬂuorescing peaks were
more frequently detected (65.7%) and, unlike JOE signals, their
intensity proved highly stable in the reproducibility analysis. In fact,
the primer pairs T7-IS1(FAM) and T7-IS2(JOE) performed equally
well when their respective products were analyzed by agarose gel
electrophoresis. Taken together, the above observations suggest that
the relatively reduced number of JOE-ﬂuorescing peaks is likely due
to the instability of the dye itself, resulting in some speciﬁc JOE peaks
being below the signal intensity threshold of 200 RFU. Therefore, to
exploit the full potential of IS6110-5030FP, it is critical to replace JOE
with a more stable and brighter dye.
In summary, we report here a new IS6110-based typing
approach, IS6110 5030-FP, which simultaneously targets IS6110 50
and 30 polymorphisms. IS6110-5030FP is unique in that IS6110
polymorphic fragments are ﬁrst pre-ampliﬁed as part of a plasmid
library, before being PCR ampliﬁed. By beneﬁting from the
resolution power and the precision of capillary DNA fragment
separation, IS6110-5030FP combines several advantages to endow it
with high-level discriminatory power, provided by the introduc-
tion of some technical reﬁnements. As a two-layer ampliﬁcation
approach that combines automated capillary electrophoresis,
IS6110-5030FP is amenable to high throughput interventional
genotyping with the ability to produce interpretable, comparable,
and storable data. Furthermore, because of its ability to detect and
to precisely resolve both 50 and 30 polymorphic fragments, IS6110-
5030FP is expected to be more phylogenetically informative and
more suitable to detect microevolution events.
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